Michiyuki Matsuda Selected Research

Michiyuki Matsuda Research Topics

Disease

17	Neoplasms (Cancer) 01/2022 - 01/2006
4	Carcinogenesis 01/2021 - 01/2014
3	Cysts 01/2013 - 06/2011
3	Glioblastoma (Glioblastoma Multiforme) 02/2012 - 01/2009
2	Neuroblastoma 01/2020 - 10/2005
1	Hypothermia 12/2020
1	Kidney Diseases (Kidney Disease) 12/2020
1	Ischemia 12/2020
1	Fibrosis (Cirrhosis) 12/2020
1	Wounds and Injuries (Trauma) 11/2018
1	Type 2 Diabetes Mellitus (MODY) 11/2017
1	Neoplasm Metastasis (Metastasis) 02/2017
1	Inflammation (Inflammations) 05/2016
1	Lewis Lung Carcinoma 05/2016
1	Shock 09/2015
1	Melanoma (Melanoma, Malignant) 04/2015
1	Enteritis 06/2014
1	Glioma (Gliomas) 04/2014
1	Colonic Neoplasms (Colon Cancer) 01/2013
1	Fibrosarcoma 05/2012
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 11/2010
1	Blast Crisis (Blast Phase) 11/2010
1	Rupture 05/2008
1	Cataract (Cataracts) 05/2008
1	Pheochromocytoma 05/2007
1	Carcinoma (Carcinomatosis) 08/2002
1	Acquired Immunodeficiency Syndrome (AIDS) 07/2002

Drug/Important Bio-Agent (IBA)

4	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 04/2019 - 01/2018
4	Proteins (Proteins, Gene)FDA Link 01/2016 - 07/2002
4	Small Interfering RNA (siRNA)IBA 04/2014 - 05/2007
3	Phosphotransferases (Kinase)IBA 04/2018 - 01/2016
2	LigandsIBA 01/2022 - 08/2002
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2021 - 01/2016
2	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 01/2021 - 01/2016
2	Indoleacetic Acids (Auxin)IBA 01/2013 - 09/2012
2	rho GTP-Binding Proteins (rho GTP-Binding Protein)IBA 01/2013 - 05/2012
2	Epidermal Growth Factor (EGF)IBA 08/2008 - 08/2002
1	Dinoprostone (PGE2)FDA Link 01/2021
1	Thromboxane A2 (A2, Thromboxane)IBA 01/2021
1	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 01/2021
1	Adenosine Triphosphate (ATP)IBA 12/2020
1	Actin Depolymerizing Factors (Cofilins)IBA 01/2020
1	Serotonin ReceptorsIBA 01/2020
1	Rho Guanine Nucleotide Exchange FactorsIBA 01/2020
1	p21-Activated KinasesIBA 01/2020
1	Protein Kinases (Protein Kinase)IBA 04/2018
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2018
1	AMP-Activated Protein KinasesIBA 11/2017
1	Deoxyribonuclease I (Nickase)IBA 02/2017
1	OsteopontinIBA 02/2017
1	Protein Isoforms (Isoforms)IBA 11/2016
1	Messenger RNA (mRNA)IBA 11/2016
1	Poly I-CIBA 05/2016
1	Transforming Growth Factors (Transforming Growth Factor)IBA 05/2016
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2016
1	motesanib diphosphateIBA 01/2016
1	Tetanus ToxinIBA 09/2015
1	PLX 4720IBA 04/2015
1	IntegrinsIBA 04/2015
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 06/2014
1	SuspensionsIBA 04/2014
1	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 01/2014
1	rho GTPase-activating proteinIBA 01/2013
1	Indicators and Reagents (Reagents)IBA 01/2013
1	Phenobarbital (Luminal)FDA Link 09/2012
1	Pharmaceutical PreparationsIBA 09/2012
1	GTP Phosphohydrolases (GTPases)IBA 02/2012
1	GelsIBA 02/2012
1	P-2 (P 2)IBA 06/2011
1	Tyrosine Kinase InhibitorsIBA 11/2010
1	Dasatinib (BMS 354825)FDA Link 11/2010
1	Imatinib Mesylate (Gleevec)FDA Link 11/2010
1	Glycoproteins (Glycoprotein)IBA 08/2009
1	TenascinIBA 08/2009
1	Monomeric GTP-Binding ProteinsIBA 01/2009
1	ErbB Receptors (EGF Receptor)IBA 08/2008
1	GuanineIBA 05/2008
1	CalciumIBA 05/2007
1	Growth Factor ReceptorsIBA 01/2006
1	Oncogene Proteins (Oncogene Protein)IBA 01/2006
1	Laminin (Merosin)IBA 10/2005

Therapy/Procedure

3	Therapeutics 07/2014 - 08/2009
1	Isogeneic Transplantation 12/2021
1	Intravenous Injections 02/2017